Group 1 - The company, 康沣生物-B (06922.HK), announced a subscription agreement with LP Investment Holdings Group and Li Jun to issue a total of 7.46 million H-shares at a subscription price of HKD 5.36 per share, representing approximately 5.20% of the existing issued H-shares and about 3.12% of the total issued shares as of the announcement date [1] - The subscription price of HKD 5.36 per share reflects a discount of approximately 17.79% compared to the closing price of HKD 6.52 per H-share on the date of the subscription agreement [1] - The total proceeds from the subscription are expected to be approximately HKD 39.99 million, with net proceeds estimated at around HKD 39.73 million after deducting expenses related to the subscription, resulting in a net issue price of approximately HKD 5.33 per share [1]
康沣生物-B(06922.HK)拟折价约17.79%配售746万股H股 净筹3973万港元